81 related articles for article (PubMed ID: 1394663)
1. Studies on cerebral protective agents. I. Novel 4-arylpyrimidine derivatives with anti-anoxic and anti-lipid peroxidation activities.
Kuno A; Sugiyama Y; Katsuta K; Kamitani T; Takasugi H
Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1452-61. PubMed ID: 1394663
[TBL] [Abstract][Full Text] [Related]
2. Studies on cerebral protective agents. II. Novel 4-arylpyrimidine derivatives with anti-anoxic and anti-lipid peroxidation activities. (2).
Kuno A; Sugiyama Y; Katsuta K; Sakai H; Takasugi H
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2423-31. PubMed ID: 1446365
[TBL] [Abstract][Full Text] [Related]
3. Studies on cerebral protective agents. III. Novel 4-arylpyrimidine derivatives with anti-anoxic and anti-lipid peroxidation activities. (3).
Kuno A; Katsuta K; Sakai H; Ohkubo M; Sugiyama Y; Takasugi H
Chem Pharm Bull (Tokyo); 1993 Jan; 41(1):139-47. PubMed ID: 8448814
[TBL] [Abstract][Full Text] [Related]
4. Studies on cerebral protective agents. VII. Synthesis of novel 4-arylazole derivatives with anti-anoxic activity.
Ohkubo M; Kuno A; Sakai H; Takasugi H
Chem Pharm Bull (Tokyo); 1995 Jun; 43(6):947-54. PubMed ID: 7641313
[TBL] [Abstract][Full Text] [Related]
5. Studies on cerebral protective agents. V. Novel 4-(3-nitrophenyl)pyridine and 4-(3-nitrophenyl)pyrimidine derivatives with anti-anoxic activity.
Kuno A; Sakai H; Ohkubo M; Takasugi H
Chem Pharm Bull (Tokyo); 1993 Jan; 41(1):163-70. PubMed ID: 8448817
[TBL] [Abstract][Full Text] [Related]
6. Studies on cerebral protective agents. VIII. Synthesis of 2-aminothiazoles and 2-thiazolecarboxamides with anti-anoxic activity.
Ohkubo M; Kuno A; Nakanishi I; Takasugi H
Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1497-504. PubMed ID: 7586073
[TBL] [Abstract][Full Text] [Related]
7. Studies on cerebral protective agents. VI. Synthesis of novel 4-(4-nitrobenzoyl)pyrimidine and related compounds with anti-anoxic activity.
Ohkubo M; Kuno A; Sakai H; Sugiyama Y; Takasugi H
Chem Pharm Bull (Tokyo); 1994 Jun; 42(6):1279-85. PubMed ID: 8069976
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of 11-[4-(cinnamyl)-1-piperazinyl]- 6,11-dihydrodibenz[b,e]oxepin derivatives, potential agents for the treatment of cerebrovascular disorders.
Kurokawa M; Sato F; Masuda Y; Yoshida T; Ochi Y; Zushi K; Fujiwara I; Naruto S; Uno H; Matsumoto J
Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2564-73. PubMed ID: 1806275
[TBL] [Abstract][Full Text] [Related]
9. [The effects of taurine on oxidative processes in brain edema].
Hovsepyan LM; Zakaryan GV; Melkonyan MM; Zakaryan AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(5):64-67. PubMed ID: 26356163
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of brain damage after focal ischemia in the rat by a novel inhibitor of lipid peroxidation.
Hara H; Kogure K; Kato H; Ozaki A; Sukamoto T
Eur J Pharmacol; 1991 May; 197(1):75-82. PubMed ID: 1893920
[TBL] [Abstract][Full Text] [Related]
11. Studies on cerebral protective agents. IV. Synthesis of novel 4-arylpyridine and 4-arylpyridazine derivatives with anti-anoxic activity.
Kuno A; Sakai H; Sugiyama Y; Takasugi H
Chem Pharm Bull (Tokyo); 1993 Jan; 41(1):156-62. PubMed ID: 8448816
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of arachidonic acid-induced vasogenic brain edema by the non-glucocorticoid 21-aminosteroid U74006F.
Hall ED; Travis MA
Brain Res; 1988 Jun; 451(1-2):350-2. PubMed ID: 3150818
[TBL] [Abstract][Full Text] [Related]
13. In vitro anti-oxidant and DNA protective effects of the novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin.
Ajith TA; Riji T; Anu V
Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):625-9. PubMed ID: 18177480
[TBL] [Abstract][Full Text] [Related]
14. Changes in n-6 and n-3 polyunsaturated fatty acids during lipid-peroxidation of mitochondria obtained from rat liver and several brain regions: effect of alpha-tocopherol.
Zanetti R; Catalá A
Prostaglandins Leukot Essent Fatty Acids; 2000 Jun; 62(6):379-85. PubMed ID: 10913231
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of certain new thiieno [2,3-d] pyrimidines as potential antitumor and radioprotective agents.
Ghorab MM; Ragab FA; Noaman E; Heiba HI; Galal M
Arzneimittelforschung; 2006; 56(7):553-60. PubMed ID: 16927539
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antiviral, antituberculostic, and antibacterial activities of some novel, 4-(4-substituted phenyl)-6-(4-nitrophenyl)-2-(substituted imino)pyrimidines.
Siddiqui AA; Rajesh R; ; Alagarsamy V; De Clercq E
Arch Pharm (Weinheim); 2007 Feb; 340(2):95-102. PubMed ID: 17294402
[TBL] [Abstract][Full Text] [Related]
17. [Antioxidant activity of a new derivative of 4-hydrazinoquinazoline in experimental cerebral hypoxia].
Dunaev VV; Belenichev IF; Kovalenko SI; Mazur IA; Siniak RS; Bashkin IN; Tishkin VS
Ukr Biokhim Zh (1978); 1993; 65(3):118-20. PubMed ID: 8291133
[TBL] [Abstract][Full Text] [Related]
18. Preparation and pharmacological evaluation of 4-(1,4-benzoquinon-2-yl)-4-phenylbutanamides as potential cerebral protective agents.
Tatsuoka T; Suzuki K; Imao K; Satoh F; Ishihara T; Hirotsu I; Kihara T; Hatta M; Horikawa Y; Sumoto K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2382-6. PubMed ID: 1446359
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of N-acetyl-serotonin on the nonenzymatic lipid peroxidation in rat testicular microsomes and mitochondria.
Gavazza MB; Català A
J Pineal Res; 2004 Oct; 37(3):153-60. PubMed ID: 15357659
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of unsymmetrical dichalcogenide, a novel antioxidant agent, in vitro and an in vivo model of brain oxidative damage.
Prigol M; Wilhelm EA; Schneider CC; Nogueira CW
Chem Biol Interact; 2008 Nov; 176(2-3):129-36. PubMed ID: 18722362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
